Exponent (EXPO)
NASDAQ:EXPO
Want to see EXPO full AI Analyst Report?
EXPO Stock Chart & Stats
$68.05
$0.25(0.29%)
At close: 4:00 PM EST
$68.05
$0.25(0.29%)
Day’s Range― - ―
52-Week Range$63.25 - $81.95
Previous CloseN/A
Volume38.01K
Average Volume (3M)341.53K
Market Cap
$3.24B
Enterprise Value$3.12B
Total Cash (Recent Filing)$221.93M
Total Debt (Recent Filing)$82.83M
Price to Earnings (P/E)33.7
Beta0.94
Next Earnings
Apr 30, 2026EPS Estimate
0.57Next Dividend Ex-DateN/A
Dividend Yield1.66%
Share Statistics
EPS (TTM)0.49
Shares Outstanding49,254,337
10 Day Avg. Volume466,482
30 Day Avg. Volume341,532
Financial Highlights & Ratios
PEG Ratio-14.35
Price to Book (P/B)9.15
Price to Sales (P/S)6.14
P/FCF Ratio29.19
Enterprise Value/Market Cap0.96
Enterprise Value/Revenue5.36
Enterprise Value/Gross Profit13.38
Enterprise Value/Ebitda20.48
Forecast
1Y Price Target
$90.00Price Target Upside32.26% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)2.26
Revenue Forecast (FY)$577.63M
Bulls Say, Bears Say
Bulls Say
AI-driven Revenue OpportunitiesManagement indicates certain business segments can capture new revenue from AI-related work, including increased demand for user research tied to AI-enabled devices.
Cash Flow And Capital AllocationRobust free cash flow and flexible capital allocation support shareholder returns via dividends and share repurchases and provide resilience through economic cycles.
GuidanceAnalyst notes management's guidance appears conservative relative to consensus, creating potential upside for the shares if execution meets or exceeds expectations.
Bears Say
Contract CancellationsAnalysts flag that contract cancellations could trigger sudden revenue declines and margin pressure if major engagements are terminated.
Skilled Labor ShortagesAnalysts warn shortages of skilled technical personnel could hinder project delivery and raise labor costs, pressuring margins and slowing growth.
Valuation SentimentAnalysts note market concerns about AI have depressed the company's valuation, limiting upside until investor sentiment stabilizes.
Exponent News
EXPO FAQ
What was Exponent’s price range in the past 12 months?
Exponent lowest stock price was $63.25 and its highest was $81.95 in the past 12 months.
What is Exponent’s market cap?
Exponent’s market cap is $3.24B.
When is Exponent’s upcoming earnings report date?
Exponent’s upcoming earnings report date is Apr 30, 2026 which is in 2 days.
How were Exponent’s earnings last quarter?
Exponent released its earnings results on Feb 05, 2026. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of $0.473 by $0.017.
Is Exponent overvalued?
According to Wall Street analysts Exponent’s price is currently Undervalued.
Does Exponent pay dividends?
Exponent pays a Quarterly dividend of $0.3 which represents an annual dividend yield of 1.66%. See more information on Exponent dividends here
What is Exponent’s EPS estimate?
Exponent’s EPS estimate is 0.57.
How many shares outstanding does Exponent have?
Exponent has 49,254,337 shares outstanding.
What happened to Exponent’s price movement after its last earnings report?
Exponent reported an EPS of $0.49 in its last earnings report, beating expectations of $0.473. Following the earnings report the stock price went up 12.651%.
Which hedge fund is a major shareholder of Exponent?
Currently, no hedge funds are holding shares in EXPO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Exponent Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$90.00 (32.26% Upside)
$90.00 (32.26% Upside)
Hedge Fund Trend
Increased
By 280.6K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $832.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.9%
Last 30 Days ▼ 3.3%
Last 30 Days ▼ 3.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-9.76%
12-Months-Change
Fundamentals
Return on Equity
25.51%
Trailing 12-Months
Asset Growth
-0.04%
Trailing 12-Months
Company Description
Exponent
Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.
EXPO Company Deck
EXPO Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive outlook: Exponent delivered a strong Q4 with revenue and EBITDA improvement, solid cash generation, aggressive capital returns, and clear demand tailwinds driven by AI, electrification and energy infrastructure work. Offsetting items include modest full-year margin compression, a small decline in FY net income, higher operating expenses (notably one-time meeting and lease items), softer Environmental & Health Q4 results and elevated year-end DSOs. Management provided constructive 2026 guidance (high-single-digit revenue growth, slight margin expansion, FTE growth and utilization targets), indicating confidence in continued recovery and secular growth drivers.View all EXPO earnings summariesEXPO Stock 12 Month Forecast
Average Price Target
$90.00
▲(32.26% Upside)
Technical Analysis
Booz Allen
―
Cra International
―
FTI Consulting
―
Huron Consulting
―
Icf International
―
Ownership Overview
1.13% Insiders
29.17% Mutual Funds
6.04% Other Institutional Investors
32.82% Public Companies and
Individual Investors